Literature DB >> 25522874

Liver-related deaths in HIV-infected patients between 1995 and 2010 in France: the Mortavic 2010 study in collaboration with the Agence Nationale de Recherche sur le SIDA (ANRS) EN 20 Mortalité 2010 survey.

E Rosenthal1, C Roussillon, D Salmon-Céron, A Georget, S Hénard, T Huleux, I Gueit, E Mortier, D Costagliola, P Morlat, G Chêne, P Cacoub.   

Abstract

OBJECTIVES: The aim of this study was to describe the proportion of liver-related diseases (LRDs) as a cause of death in HIV-infected patients in France and to compare the results with data from our five previous surveys.
METHODS: In 2010, 24 clinical wards prospectively recorded all deaths occurring in around 26 000 HIV-infected patients who were regularly followed up. Results were compared with those of previous cross-sectional surveys conducted since 1995 using the same design.
RESULTS: Among 230 reported deaths, 46 (20%) were related to AIDS and 30 (13%) to chronic liver diseases. Eighty per cent of patients who died from LRDs had chronic hepatitis C, 16.7% of them being coinfected with hepatitis B virus (HBV). Among patients who died from an LRD, excessive alcohol consumption was reported in 41%. At death, 80% of patients had undetectable HIV viral load and the median CD4 cell count was 349 cells/μL. The proportion of deaths and the mortality rate attributable to LRDs significantly increased between 1995 and 2005 from 1.5% to 16.7% and from 1.2‰ to 2.0‰, respectively, whereas they tended to decrease in 2010 to 13% and 1.1‰, respectively. Among liver-related causes of death, the proportion represented by hepatocellular carcinoma (HCC) dramatically increased from 5% in 1995 to 40% in 2010 (p = 0.019).
CONCLUSIONS: The proportion of LRDs among causes of death in HIV-infected patients seems recently to have reached a plateau after a rapid increase during the decade 1995-2005. LRDs remain a leading cause of death in this population, mainly as a result of hepatitis C virus (HCV) coinfection, HCC representing almost half of liver-related causes of death.
© 2014 British HIV Association.

Entities:  

Keywords:  HIV; cirrhosis; hepatitis B virus; hepatitis C virus; hepatocellular carcinoma; mortality

Mesh:

Year:  2014        PMID: 25522874     DOI: 10.1111/hiv.12204

Source DB:  PubMed          Journal:  HIV Med        ISSN: 1464-2662            Impact factor:   3.180


  22 in total

1.  Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Co-Infection Among HIV Infected Individuals at Tertiary Care Hospital in Western Nepal.

Authors:  Hosuru Subramanya Supram; Shishir Gokhale; Brijesh Sathian; Dharma Raj Bhatta
Journal:  Nepal J Epidemiol       Date:  2015-06-01

Review 2.  HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment.

Authors:  Kasha P Singh; Megan Crane; Jennifer Audsley; Anchalee Avihingsanon; Joe Sasadeusz; Sharon R Lewin
Journal:  AIDS       Date:  2017-09-24       Impact factor: 4.177

Review 3.  Screening for Hepatocellular Carcinoma in HIV-Infected Patients: Current Evidence and Controversies.

Authors:  N Merchante; M Rodríguez-Fernández; J A Pineda
Journal:  Curr HIV/AIDS Rep       Date:  2020-02       Impact factor: 5.071

4.  Trends in Incidences and Risk Factors for Hepatocellular Carcinoma and Other Liver Events in HIV and Hepatitis C Virus-coinfected Individuals From 2001 to 2014: A Multicohort Study.

Authors:  Lars I Gjærde; Leah Shepherd; Elzbieta Jablonowska; Adriano Lazzarin; Mathieu Rougemont; Katharine Darling; Manuel Battegay; Dominique Braun; Valerie Martel-Laferriere; Jens D Lundgren; Jürgen K Rockstroh; John Gill; Andri Rauch; Amanda Mocroft; Marina B Klein; Lars Peters
Journal:  Clin Infect Dis       Date:  2016-06-15       Impact factor: 9.079

5.  Ultrasound shear wave elastography and liver fibrosis: A Prospective Multicenter Study.

Authors:  Joyce Anyona Sande; Suleman Verjee; Sudhir Vinayak; Farin Amersi; Munir Ghesani
Journal:  World J Hepatol       Date:  2017-01-08

6.  Human immunodeficiency virus and liver disease: A comprehensive update.

Authors:  Kenneth E Sherman; Marion G Peters; David Thomas
Journal:  Hepatol Commun       Date:  2017-11-06

7.  Multiple cause-of-death data among people with AIDS in Italy: a nationwide cross-sectional study.

Authors:  Enrico Grande; Antonella Zucchetto; Barbara Suligoi; Francesco Grippo; Marilena Pappagallo; Saverio Virdone; Laura Camoni; Martina Taborelli; Vincenza Regine; Diego Serraino; Luisa Frova
Journal:  Popul Health Metr       Date:  2017-05-18

8.  A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi Sarcoma.

Authors:  Thomas S Uldrick; Priscila H Gonçalves; Kathleen M Wyvill; Cody J Peer; Wendy Bernstein; Karen Aleman; Mark N Polizzotto; David Venzon; Seth M Steinberg; Vickie Marshall; Denise Whitby; Richard F Little; John J Wright; Michelle A Rudek; William D Figg; Robert Yarchoan
Journal:  Oncologist       Date:  2017-03-24

9.  Incidence of AIDS-Defining Opportunistic Infections and Mortality during Antiretroviral Therapy in a Cohort of Adult HIV-Infected Individuals in Hanoi, 2007-2014.

Authors:  Junko Tanuma; Kyu Ha Lee; Sebastien Haneuse; Shoko Matsumoto; Dung Thi Nguyen; Dung Thi Hoai Nguyen; Cuong Duy Do; Thuy Thanh Pham; Kinh Van Nguyen; Shinichi Oka
Journal:  PLoS One       Date:  2016-03-03       Impact factor: 3.240

10.  Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study.

Authors:  Mariam Noelie Hema; Tristan Ferry; Michel Dupon; Lise Cuzin; Renaud Verdon; Rodolphe Thiébaut; Camelia Protopopescu; Catherine Leport; François Raffi; Vincent Le Moing
Journal:  PLoS One       Date:  2016-08-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.